-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Public Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI™
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Public Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREWORKING AT IQVIA
Our mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORELIFE AT IQVIA
Careers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
WE’RE HIRING
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSBlog
Patient-centric Care in Rare Diseases
Feb 28, 2017
28 February 2017 marks the tenth international Rare Disease Day, and its strapline this year is 'with research, possibilities are limitless'. Held every year on the last day of February, Rare Disease Day raises awareness of the 6000+ rare diseases found around the world, each affecting somewhere between a handful and a few hundred thousand people. Around 80% of rare or ‘orphan’ diseases have a genetic origin, and 75% of rare diseases affect children.
There are treatments available for some rare diseases, but diagnosis may be difficult and because symptoms may be relatively non-specific, misdiagnosis or missed diagnosis are common. This is compounded when symptoms of a single disease vary between individuals. Once a patient is correctly diagnosed, they can find that care may not be available locally, so patients and their families may have to travel many miles to get the treatment they need. These challenges make patient-centric care particularly important in people with rare diseases.
Changing biopharma’s focus towards rare diseases
As competition increases within therapeutics for the more common and chronic conditions – often described as the ‘low hanging fruit’ – biopharma development is increasingly focusing on opportunities to meet patient needs within rare diseases. These are often the first drug specifically indicated for a particular rare disorder, so there is a lot riding on their success. However, because R&D timelines are compressed and clinical trial sizes much smaller, there is a certain degree of risk in their development as well as post approval regulatory requirements.
Looking at rare disease from the patient’s perspective
Providing patient-centric programs around treatments for rare diseases, whether tablet, injectable or inhalation, is a complex challenge, because these must take into account the requirements of the families and carers as well as the patients. They must also be flexible, as different patients with the same disease may have different needs, and these needs are likely to change as their disease progresses and the patient gets older.
By their very nature, many doctors may only see a handful of patients with rare diseases. In contrast, patients’ parents and carers, and the patients themselves, are likely to have built up a lot of knowledge and expertise through everyday hands on care, through networks of other families, and by getting involved in patient groups. They may have had to fight for diagnosis and treatment, and may have concerns about their future. While some rare diseases are life-limiting or life-threatening, in others, patients will grow up and live independently, and their needs for care and treatment will evolve over time.
Creating patient-centric support programs for rare diseases
Understanding the rare disease from the patient’s perspective will provide vital insight into creating patient-centric programs that meet the needs of the patient and family but that can be tailored to the individual circumstance, and to the points on life and patient journeys. As many of the patients with rare diseases are children, with different levels of cognition according to their age and the type of disease, the design of the support program, from personal support to apps and wearables, needs to take this into account. For instance, a 6-year old child with a disorder that is managed very carefully with behaviour modification as well as medication cannot be treated the same as a teenager who is starting to create a life outside their home and family.
A number of therapeutics for rare diseases gain accelerated approval on a limited patient population and a small number of clinical trials. This has the benefit that the drugs reach the patients more quickly, but the approval is only conditional. Because of this, the support program needs to be able to track patient outcomes and benefits, and flag up any safety issues that may emerge. This data can then be used to support full approval.
To be effective in rare diseases, where patients are likely to be spread across long distances, patient support programs need to be well co-ordinated, and the mode of delivery for the information and support has to be considered carefully. Here, digital approaches can be very powerful, with one-on-one contact through Skype, and educational material available through apps and websites.
A single support program cannot meet all the needs of all the people, and so to be effective for the patients and carers, and to be cost-effective for the physicians and payers, it’s important to focus on the greatest need, which may be specific to one point in the pathway of a single disease, or potentially work across a number of different conditions.